Literature DB >> 2471783

Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.

C Bolwell1, B E Clarke, N R Parry, E J Ouldridge, F Brown, D J Rowlands.   

Abstract

Epitopes of strain A22 Iraq 24/64 of foot-and-mouth disease virus have been mapped with monoclonal antibodies (MAbs). Three methods were used: (i) an indirect ELISA using an overlapping set of peptides, (ii) production of neutralization escape variants against each MAb and (iii) sequencing of neutralization escape variants. The study has shown that the virus has at least three overlapping liner neutralizing epitopes within a major antigenic site on VP1. The presence of a second, conformational site was demonstrated but its position on the virus particle was not located. Synthetic peptides with sequences representing the major site elicit antibodies which have similar broad cross-neutralizing activity to polyclonal serum or neutralizing MAbs produced with the virus against a range of field isolates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471783     DOI: 10.1099/0022-1317-70-1-59

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  24 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.

Authors:  J C Saiz; M J Gonzalez; M V Borca; F Sobrino; D M Moore
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  Antigenic stability of foot-and-mouth disease virus variants on serial passage in cell culture.

Authors:  M J Gonzalez; J C Saiz; O Laor; D M Moore
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 4.  An overview on ELISA techniques for FMD.

Authors:  Li-na Ma; Jie Zhang; Hao-tai Chen; Jian-hua Zhou; Yao-zhong Ding; Yong-sheng Liu
Journal:  Virol J       Date:  2011-09-04       Impact factor: 4.099

Review 5.  Development of foot-and-mouth disease virus strain characterisation--a review.

Authors:  R P Kitching; N J Knowles; A R Samuel; A I Donaldson
Journal:  Trop Anim Health Prod       Date:  1989-08       Impact factor: 1.559

6.  Mapping antigenic sites on the major outer membrane protein of Chlamydia trachomatis with synthetic peptides.

Authors:  G M Zhong; R E Reid; R C Brunham
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

7.  Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides.

Authors:  M J Francis; G Z Hastings; B E Clarke; A L Brown; C R Beddell; D J Rowlands; F Brown
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

8.  Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.

Authors:  M G Mateu; J Hernández; M A Martínez; D Feigelstock; S Lea; J J Pérez; E Giralt; D Stuart; E L Palma; E Domingo
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Antigenic variation of foot-and-mouth disease virus serotype A.

Authors:  A B Ludi; D L Horton; Y Li; M Mahapatra; D P King; N J Knowles; C A Russell; D J Paton; J L N Wood; D J Smith; J M Hammond
Journal:  J Gen Virol       Date:  2013-11-01       Impact factor: 3.891

10.  Determining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses.

Authors:  Pamela A Opperman; Lia S Rotherham; Jan Esterhuysen; Bryan Charleston; Nicholas Juleff; Alejandra V Capozzo; Jacques Theron; Francois F Maree
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.